SOPHiA GENETICS
SOPH
SOPH
29 hedge funds and large institutions have $167M invested in SOPHiA GENETICS in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
36% less capital invested
Capital invested by funds: $262M → $167M (-$95M)
Holders
29
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$16.2M | |
| 2 | +$6.42M | |
| 3 | +$1.76M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$604K |
| 5 |
BPCA
Bank Pictet & Cie (Asia)
Singapore
|
+$498K |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$568K | |
| 3 | -$484K | |
| 4 |
Millennium Management
New York
|
-$374K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$200K |